Malignant Melanoma Clinical Trials in Ramat Gan
2 recruitingRamat Gan, Israel
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Malignant Melanoma
Merck Sharp & Dohme LLC160 enrolled38 locationsNCT06961006
Recruiting
Phase 2
Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients
Malignant Melanoma Stage IV
Sheba Medical Center30 enrolled1 locationNCT03166397